New Information about Teriflunomide
Dr. Kantor talks with Dr. Mark Freedman, Professor of Medicine Neurology at University Ottawa and Director of MS Research Unit at Ottawa Hospital about new information on Teriflunomide.
Click here or on the graphic to the left to watch now.
Phase 1 Stem Cell Trial
Dr. Kantor talks with Dr. Jeff Cohen, Director of the Scientific Program Committee of ACTRIMS-ECTRIMS and Director of the Mellan Center at the Cleveland Clinic about a Phase 1 Stem Cell Trial.
Click here or on the graphic to the right to watch now.
Click on the images above to watch each day's coverage.
|